RE:Cash & revenueYes, you are somewhat correct, however, on the other hand, the potential of a stock based on the past performance and experience of the principal company owners holds a valuation as well. As an IPO, this stock has room to align with MMED in share price and then overtake SHRM and MMED by leaps and bounds. TRIP has entered into agreements with RVV and others to get their product moving. As far as profit potential, TRIP, will produce vast amounts of revenue very quickly because it has entered into the recreational use of these compounds. Recreational use is why the pot sector took off like it did. People want to get high! So, let them. Let them get their parties started legally in Europe, supplied by a reputable company. This company will generate revenue, and generate it quickly in high volume.